Compared to developing a genetically engineered K562 feeder cell system from scratch, using Hillgene's GMP-grade K562 feeder cells can significantly reduce R&D burden:
· Saves approximately 1 year of development time
· Reduces R&D costs by around USD 3 million
· Lowers risks associated with CMC development and process validation
· Accelerates the IND submission process
Discover more about our product: Genetically Modified K562 Feeder Cell - Hillgene Biopharma Co., Ltd.
86 198 5711 6962 
info@hillgene.com 
English
![[GMP revised] Appendix for “Investigational Drugs (Interim)” issued and taking effect as of July 1!](/uploads/image/20250603/gmp-revised-appendix-for-investigational-drugs-interim-issued-and-taking-effect-as-of-july-1.webp "[GMP revised] Appendix for “Investigational Drugs (Interim)” issued and taking effect as of July 1!")